Anika Therapeutics (ANIK) Tops Q2 EPS by 35c
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $20.81 --0%
EPS Growth %: -25.0%
Financial Fact:
Income from operations: 13.69M
Today's EPS Names:
ALZN, ASPU, OCCI, More
EPS Growth %: -25.0%
Financial Fact:
Income from operations: 13.69M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Anika Therapeutics (NASDAQ: ANIK) reported Q2 EPS of $0.68, $0.35 better than the analyst estimate of $0.33. Revenue for the quarter came in at $30.5 million versus the consensus estimate of $27.9 million.
For earnings history and earnings-related data on Anika Therapeutics (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- B.Riley Assumes Anika Therapeutics (ANIK) at Buy
- Redburn upgrades Southwest, stays bullish on Delta and United
- JPMorgan Reiterates Overweight Rating on Samsung Electronics Co Ltd. (005930:KS) (SSNLF)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
